Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines-Possible Implications in New Therapeutic Strategies.

Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, Pop L, Raduly L, Barbat A, Moldovan A, Moldovan C, Tigu AB, Ionescu C, Atanasov AG, Irimie A, Berindan-Neagoe I.

Int J Mol Sci. 2019 Mar 9;20(5). pii: E1199. doi: 10.3390/ijms20051199.

2.

Novel therapeutic strategies for stroke: The role of autophagy.

Nabavi SF, Sureda A, Sanches-Silva A, Pandima Devi K, Ahmed T, Shahid M, Sobarzo-Sánchez E, Dacrema M, Daglia M, Braidy N, Vacca RA, Berindan-Neagoe I, Gulei D, Barreca D, Banach M, Nabavi SM, Dehpour AR, Shirooie S.

Crit Rev Clin Lab Sci. 2019 May;56(3):182-199. doi: 10.1080/10408363.2019.1575333. Epub 2019 Mar 1.

PMID:
30821184
3.

Comprehensive analysis of circular RNAs in pathological states: biogenesis, cellular regulation, and therapeutic relevance.

Braicu C, Zimta AA, Gulei D, Olariu A, Berindan-Neagoe I.

Cell Mol Life Sci. 2019 Apr;76(8):1559-1577. doi: 10.1007/s00018-019-03016-5. Epub 2019 Feb 25. Review.

PMID:
30805658
4.

Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.

Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S.

Pharmacol Res. 2019 Mar;141:466-480. doi: 10.1016/j.phrs.2019.01.014. Epub 2019 Jan 11. Review.

PMID:
30639373
5.

CRISPR-based RNA editing: diagnostic applications and therapeutic options.

Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242. Epub 2019 Jan 21. No abstract available.

PMID:
30632384
6.

The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes.

Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I.

Cells. 2019 Jan 8;8(1). pii: E29. doi: 10.3390/cells8010029. Review.

7.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

8.

Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools.

Gulei D, Petrut B, Tigu AB, Onaciu A, Fischer-Fodor E, Atanasov AG, Ionescu C, Berindan-Neagoe I.

Crit Rev Biochem Mol Biol. 2018 Oct;53(5):564-577. doi: 10.1080/10409238.2018.1508276. Epub 2018 Sep 24. Review.

PMID:
30247075
9.

Combined Therapy in Cancer: The Non-coding Approach.

Gulei D, Berindan-Neagoe I.

Mol Ther Nucleic Acids. 2018 Sep 7;12:787-792. doi: 10.1016/j.omtn.2018.07.013. Epub 2018 Jul 31. No abstract available.

10.

Phytol: A review of biomedical activities.

Islam MT, Ali ES, Uddin SJ, Shaw S, Islam MA, Ahmed MI, Chandra Shill M, Karmakar UK, Yarla NS, Khan IN, Billah MM, Pieczynska MD, Zengin G, Malainer C, Nicoletti F, Gulei D, Berindan-Neagoe I, Apostolov A, Banach M, Yeung AWK, El-Demerdash A, Xiao J, Dey P, Yele S, Jóźwik A, Strzałkowska N, Marchewka J, Rengasamy KRR, Horbańczuk J, Kamal MA, Mubarak MS, Mishra SK, Shilpi JA, Atanasov AG.

Food Chem Toxicol. 2018 Nov;121:82-94. doi: 10.1016/j.fct.2018.08.032. Epub 2018 Aug 18.

PMID:
30130593
11.

Overview upon miR-21 in lung cancer: focus on NSCLC.

Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I.

Cell Mol Life Sci. 2018 Oct;75(19):3539-3551. doi: 10.1007/s00018-018-2877-x. Epub 2018 Jul 20. Review.

PMID:
30030592
12.

Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials.

Nabavi SF, Atanasov AG, Khan H, Barreca D, Trombetta D, Testai L, Sureda A, Tejada S, Vacca RA, Pittalà V, Gulei D, Berindan-Neagoe I, Shirooie S, Nabavi SM.

Cancer Lett. 2018 Oct 10;434:101-113. doi: 10.1016/j.canlet.2018.07.018. Epub 2018 Jul 17.

PMID:
30030139
13.

The foundation of personalized medicine is the establishment of biobanks and their standardization.

Policiuc L, Buse M, Gulei D, Andreea Zimta A, Braicu C, Iulia Irimie A, Berindan-Neagoe I.

J BUON. 2018 May-Jun;23(3):550-560.

14.

Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.

Sonea L, Buse M, Gulei D, Onaciu A, Simon I, Braicu C, Berindan-Neagoe I.

Curr Genomics. 2018 May;19(4):258-278. doi: 10.2174/1389202918666171005100124.

15.

Current Insights into Oral Cancer Epigenetics.

Irimie AI, Ciocan C, Gulei D, Mehterov N, Atanasov AG, Dudea D, Berindan-Neagoe I.

Int J Mol Sci. 2018 Feb 27;19(3). pii: E670. doi: 10.3390/ijms19030670. Review.

16.

Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.

Chira S, Gulei D, Hajitou A, Berindan-Neagoe I.

Trends Biotechnol. 2018 Jul;36(7):653-660. doi: 10.1016/j.tibtech.2018.01.014. Epub 2018 Feb 22. Review.

17.

Exosomes-Small Players, Big Sound.

Gulei D, Irimie AI, Cojocneanu-Petric R, Schultze JL, Berindan-Neagoe I.

Bioconjug Chem. 2018 Mar 21;29(3):635-648. doi: 10.1021/acs.bioconjchem.8b00003. Epub 2018 Feb 9. Review.

PMID:
29369619
18.

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.

Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop LA, Moisoiu V, Budisan L, Pop-Bica C, Ciocan C, Buiga R, Muresan MS, Stiufiuc R, Ionescu C, Berindan-Neagoe I.

Cell Death Dis. 2018 Jan 19;9(2):66. doi: 10.1038/s41419-017-0102-8.

19.

CRISPR/Cas9: A Potential Life-Saving Tool. What's next?

Gulei D, Berindan-Neagoe I.

Mol Ther Nucleic Acids. 2017 Dec 15;9:333-336. doi: 10.1016/j.omtn.2017.10.013. Epub 2017 Nov 10. No abstract available.

20.

Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum.

Khan H, Nabavi SM, Sureda A, Mehterov N, Gulei D, Berindan-Neagoe I, Taniguchi H, Atanasov AG.

Eur J Med Chem. 2018 Jun 10;153:29-33. doi: 10.1016/j.ejmech.2017.10.065. Epub 2017 Nov 11. Review.

PMID:
29133056

Supplemental Content

Loading ...
Support Center